Cardiol Therapeutics Inc. (CRDL)
NASDAQ: CRDL · Real-Time Price · USD
1.150
+0.010 (0.88%)
At close: Oct 15, 2026, 4:00 PM EDT
1.182
+0.032 (2.76%)
After-hours: Oct 15, 2026, 7:59 PM EDT
Cardiol Therapeutics Market Cap
Cardiol Therapeutics has a market cap or net worth of $131.66 million as of October 15, 2026. Its market cap has increased by 51.30% in one year.
Market Cap
131.66M
Enterprise Value
113.36M
1-Year Change
51.30%
Global Rank
n/a
Country Rank
n/a
Category
ChartMarket Cap Chart
Since December 20, 2018, Cardiol Therapeutics's market cap has increased from $69.77M to $131.66M, an increase of 88.71%. That is a compound annual growth rate of 8.45%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 15, 2026 | 131.66M | 38.47% |
| Dec 31, 2025 | 95.08M | -9.38% |
| Dec 31, 2024 | 104.92M | 93.06% |
| Dec 29, 2023 | 54.35M | 67.34% |
| Dec 30, 2022 | 32.48M | -71.06% |
| Dec 31, 2021 | 112.23M | 56.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 20, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BioAge Labs | 255.65M |
| Lifecore Biomedical | 243.02M |
| SIGA Technologies | 221.30M |
| ADC Therapeutics | 217.04M |
| Akebia Therapeutics | 213.37M |
| Journey Medical | 160.31M |
| Organogenesis Holdings | 155.70M |
| BGM Group | 139.95M |